W. Gerald Austen is Director at ABIOMED INC (ABMD). They have made 6 open-market trades across 1 company since 2012, most recently 2015-08-12.
CIK 0001203056
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 6 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ABMD | 87,241 | $33.2M |
Shares reported on the most recent Form 4, priced at the 2015-08-14 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ABMD | SELL | 2015-02-24 | 2015-02-26 | $60.62 | $364K | -3.4% | -4.0% | -4.0% |
| ABMD | SELL | 2015-02-12 | 2015-02-18 | $58.65 | $469K | -3.4% | -4.0% | -4.0% |
| ABMD | SELL | 2014-02-13 | 2014-02-18 | $28.20 | $226K | -3.4% | -4.0% | -4.0% |
| ABMD | SELL | 2013-11-08 | 2013-11-13 | $25.72 | $206K | -3.4% | -4.0% | -4.0% |
| ABMD | SELL | 2013-08-05 | 2013-08-07 | $22.85 | $183K | -3.4% | -4.0% | -4.0% |
| ABMD | SELL | 2012-11-05 | 2012-11-07 | $13.26 | $265K | -3.4% | -4.0% | -4.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.